|
MAPK8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07479589064974E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.08470004884276E-09 |
| Normal-vs-Stage2 |
5.54759999999987E-05 |
| Normal-vs-Stage3 |
4.30929736339181E-11 |
| Normal-vs-Stage4 |
2.54080001482748E-09 |
| Stage1-vs-Stage2 |
7.063600E-01 |
| Stage1-vs-Stage3 |
6.640400E-02 |
| Stage1-vs-Stage4 |
6.702400E-02 |
| Stage2-vs-Stage3 |
9.418000E-02 |
| Stage2-vs-Stage4 |
6.590100E-02 |
| Stage3-vs-Stage4 |
6.506000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.88800086675656E-11 |
| Normal-vs-AfricanAmerican |
2.620200E-03 |
| Normal-vs-Asian |
6.220299997306E-08 |
| Caucasian-vs-AfricanAmerican |
2.498400E-01 |
| Caucasian-vs-Asian |
7.351600E-01 |
| AfricanAmerican-vs-Asian |
1.874840E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70879993383255E-11 |
| Normal-vs-Female |
5.86160009419245E-10 |
| Male-vs-Female |
1.495200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.91299999677364E-08 |
| Normal-vs-Age(41-60Yrs) |
2.77949996352334E-09 |
| Normal-vs-Age(61-80Yrs) |
1.56080037783113E-10 |
| Normal-vs-Age(81-100Yrs) |
3.463700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.438600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.260800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.480800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.276000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.351000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.259400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.963600E-03 |
| Classical-VS-Follicular |
6.700300E-02 |
| Classical-VS-Other |
3.663400E-01 |
| Classical-VS-Normal |
9.89530679618156E-12 |
| Tall-VS-Follicular |
7.161400E-04 |
| Tall-VS-Other |
9.217000E-01 |
| Tall-VS-Normal |
7.85810305714563E-11 |
| Follicular-VS-Other |
2.284600E-01 |
| Follicular-VS-Normal |
1.059220E-03 |
| Other-VS-Normal |
2.097600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35679994911686E-09 |
| Normal-vs-N1 |
5.70519964604443E-10 |
| N0-vs-N1 |
3.544400E-02 |
|
|
